NCT02013115View on ClinicalTrials.gov

Curosurf/Budesonide for Infants With Respiratory Distress Syndrome

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

October 30, 2017

Study Completion Date

October 30, 2017

Conditions
Respiratory Distress Syndrome
Interventions
DRUG

Budesonide

Experimental: Cursurf and Budesonide The baby with respiratory distress syndrome was given Cursurf and Budesonide through intubation

Trial Locations (1)

400042

Department of Pediatrics, Daping Hospital, Research Institute of Surgery, Third Military Medical University, Chongqing

All Listed Sponsors
lead

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

OTHER

NCT02013115 - Curosurf/Budesonide for Infants With Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter